• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在因良性前列腺增生而接受手术的患者中,是否存在 PSA 截断值可提示偶发前列腺癌?

Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?

机构信息

Department of Urology, Istanbul University Istanbul School of Medicine, Istanbul.

Department of Urology, University of Health Sciences, Ankara City Hospital, Ankara.

出版信息

Arch Ital Urol Androl. 2021 Mar 18;93(1):31-34. doi: 10.4081/aiua.2021.1.31.

DOI:10.4081/aiua.2021.1.31
PMID:33754606
Abstract

AIM

To investigate incidental prostate cancer (IPCa) rate and to determine prostate specific antigen (PSA) cut-off value indicating PCa in patients who underwent surgery by being diagnosed with benign prostatic hyperplasia (BPH) clinically or by standard prostate biopsy.

METHODS

Data of 317 patients, who underwent transurethral resection of the prostate (TURP) or open prostatectomy (OP) with pre-diagnosis of BPH, were evaluated retrospectively. The examined parameters included patients' demographics, preoperative serum PSA values, digital rectal examination (DRE) findings, surgical method, histopathological findings and Gleason Scores.

RESULTS

A total of 317 patients were included the study. The median age of patients was 69 years (min: 51-max: 79) and the median PSA value was 3.24 ng/dl (min: 0.17-max: 34.9). In 21 patients (6.6%); DRE findings were in favor of malignancy, but prostate biopsy resulted as BPH. While 281 (88.6%) of the patients underwent TURP, 36 (11.4%) underwent open prostatectomy. PCa was detected in 21 (6.6%) patients. PSA was statistically higher in patients who underwent OP compared to patient who underwent TUR-P, 5.9 (min: 1.2 - max: 27.6, IR: 8.7) vs. 2.8 (min: 0.1-max: 34.9, IR: 4.2) ng/dl, p < .001. The rate of IPCa among four PSA group was similar (p = 0.46). There was no difference between the rate of IPCa in patients younger and older than 70 years, (p = 0.11). Please change whole sentence as 'The median PSA level was slightly higher in patients diagnosed with BPH compared to patients diagnosed with IPCa, 3.2 (min: 0.1-max: 34.9) vs. 2.7 (min: 0.3-max: 26.5) ng/dL, p = 0.9.

CONCLUSIONS

IPCa still remains an important clinical problem. We were not able to find any correlation of PSA and age with incidental PCa.

摘要

目的

研究经临床诊断为良性前列腺增生(BPH)或经标准前列腺活检诊断为良性前列腺增生(BPH)患者手术中偶然发现的前列腺癌(IPCa)发生率,并确定提示前列腺癌(PCa)的前列腺特异性抗原(PSA)截断值。

方法

回顾性分析 317 例经尿道前列腺电切术(TURP)或开放性前列腺切除术(OP)的患者资料。检查参数包括患者的人口统计学资料、术前血清 PSA 值、直肠指检(DRE)结果、手术方法、组织病理学结果和 Gleason 评分。

结果

共有 317 例患者纳入研究。患者的中位年龄为 69 岁(最小:51-最大:79),中位 PSA 值为 3.24ng/dl(最小:0.17-最大:34.9)。21 例患者(6.6%);DRE 检查结果倾向于恶性,但前列腺活检结果为 BPH。281 例患者(88.6%)接受 TURP 治疗,36 例(11.4%)接受开放性前列腺切除术。21 例(6.6%)患者发现前列腺癌。与接受 TURP 治疗的患者相比,接受 OP 治疗的患者 PSA 水平更高,分别为 5.9(最小:1.2-最大:27.6,IR:8.7)和 2.8(最小:0.1-最大:34.9,IR:4.2)ng/dl,p<0.001。四个 PSA 组的 IPCa 发生率相似(p=0.46)。70 岁以上和 70 岁以下患者的 IPCa 发生率无差异(p=0.11)。

结论

偶然发现的前列腺癌仍然是一个重要的临床问题。我们未能发现 PSA 与年龄与偶然发现的前列腺癌之间存在任何相关性。

相似文献

1
Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?在因良性前列腺增生而接受手术的患者中,是否存在 PSA 截断值可提示偶发前列腺癌?
Arch Ital Urol Androl. 2021 Mar 18;93(1):31-34. doi: 10.4081/aiua.2021.1.31.
2
"Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).“大海捞针”:接受钬激光前列腺剜除术(HoLEP)与经尿道前列腺切除术(TURP)治疗下尿路症状(LUTS)的患者的肿瘤评估。
World J Urol. 2017 Nov;35(11):1777-1782. doi: 10.1007/s00345-017-2048-y. Epub 2017 May 17.
3
Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.前列腺增生症各种手术干预后,术后前列腺特异抗原(PSA)及PSA速率可确定前列腺癌的存在。
Urology. 2009 Jul;74(1):177-83. doi: 10.1016/j.urology.2008.10.062. Epub 2009 May 9.
4
Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.经尿道前列腺切除标本中偶然发现的前列腺腺癌:一项来自印度的基于医院的研究
Asian Pac J Cancer Prev. 2016;17(4):2255-8. doi: 10.7314/apjcp.2016.17.4.2255.
5
Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary?对良性前列腺增生手术标本进行系统的组织学分析总是必要的吗?
Int Urol Nephrol. 2022 Jul;54(7):1485-1489. doi: 10.1007/s11255-022-03220-6. Epub 2022 May 10.
6
Evaluation of factors associated with the detection of incidental prostate cancer after open prostatectomy for benign prostatic hyperplasia.评估与经尿道前列腺切除术治疗良性前列腺增生术后偶然发现前列腺癌相关的因素。
Andrologia. 2022 Feb;54(1):e14261. doi: 10.1111/and.14261. Epub 2021 Sep 29.
7
Accuracy of the preoperative PSA level for predicting clinically significant incidental transitional zone-prostate cancer before endoscopic enucleation of very large adenoma.术前 PSA 水平预测内镜下前列腺大腺瘤剜除术时偶然发现的临床显著移行区前列腺癌的准确性。
World J Urol. 2020 Apr;38(4):993-1000. doi: 10.1007/s00345-019-02823-6. Epub 2019 May 28.
8
"In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.“腔内”MRI前列腺活检是一种安全的术前临床工具,用于在经尿道激光剜除术前排除有良性前列腺梗阻症状的患者是否患有严重前列腺癌。
Arch Ital Urol Androl. 2020 Jan 14;91(4):224-229. doi: 10.4081/aiua.2019.4.224.
9
Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era.在 MRI 时代,接受良性前列腺梗阻手术的患者中偶然发现前列腺癌的患病率和潜在预测因素:一项回顾性研究。
World J Urol. 2024 Aug 14;42(1):485. doi: 10.1007/s00345-024-05171-2.
10
The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates.术前 PSA 水平升高对大体积前列腺下尿路症状患者偶发前列腺癌检测的意义。
World J Urol. 2021 May;39(5):1481-1487. doi: 10.1007/s00345-020-03321-w. Epub 2020 Jun 25.

引用本文的文献

1
Application of mean maximum Young's modulus value as a new parameter for differential diagnosis of prostate diseases.应用平均最大杨氏模量值作为前列腺疾病鉴别诊断的新参数。
Sci Rep. 2025 Jan 30;15(1):3832. doi: 10.1038/s41598-025-88263-2.
2
Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis.某些良性前列腺增生症手术中偶发前列腺癌的患病率及危险因素:系统评价和荟萃分析。
Int Braz J Urol. 2022 Nov-Dec;48(6):915-929. doi: 10.1590/S1677-5538.IBJU.2021.0653.